TRAPPC8 Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Description

Structure and Conjugation Mechanism

TRAPPC8 antibodies target specific epitopes within the protein’s 1,435-amino-acid sequence. The FITC conjugate is created by chemically linking the FITC fluorophore to the antibody, enabling fluorescence-based detection. Key structural features include:

  • Epitope Regions: Antibodies often target the N-terminal (e.g., aa 1–603) or C-terminal (e.g., aa 880–894, 1270–1285) domains .

  • Conjugation Protocol: FITC binds to lysine residues via isothiocyanate groups, maintaining antibody specificity while enabling fluorescence emission at 519 nm .

Applications in Research

TRAPPC8-FITC antibodies are used in multiple experimental workflows:

ApplicationProtocolKey Findings
Immunofluorescence (IF)Colocalization with Golgi markersTRAPPC8 localizes to ER exit sites and centrosomes .
Flow CytometryCell-surface staining for HPV studiesTRAPPC8 knockdown reduces HPV PsV internalization .
Confocal MicroscopyColocalization with L1 capsid proteinsTRAPPC8 exposure on cell surfaces increases post-HPV inoculation .

Role in Viral Entry

TRAPPC8 interacts with HPV L2 capsid proteins, facilitating viral entry. Knockdown reduced GFP reporter expression by 60–80% in HPV51/16/31 pseudovirus (PsV) models .

Ciliogenesis and Centriolar Function

TRAPPC8 colocalizes with OFD1 at centrosomes and regulates centriolar satellite assembly. TRAPPC8−/− cells show disrupted cilia formation, highlighting its role in microtubule dynamics .

Experimental Validation

  • HPV Studies: Anti-TRAPPC8 (aa 880–894) colocalized with HPV L1 capsids on HeLa cell surfaces, confirmed via confocal microscopy .

  • Co-IP Assays: TRAPPC8 co-precipitated with TRAPPC12 and OFD1, indicating its role in TRAPPIII complex interactions .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days after receiving it. Delivery times may vary depending on the purchase method and location. Please consult your local distributor for specific delivery information.
Synonyms
General sporulation gene 1 homolog antibody; GSG1 antibody; HsT2706 antibody; KIAA1012 antibody; Protein TRS85 homolog antibody; TPPC8_HUMAN antibody; Trafficking protein particle complex subunit 8 antibody; TRAPPC8 antibody; TRS85 antibody
Target Names
TRAPPC8
Uniprot No.

Target Background

Function
TRAPPC8 plays a crucial role in the early stages of endoplasmic reticulum to Golgi apparatus trafficking. In conjunction with TBC1D14, it maintains the cycling pool of ATG9, which is essential for initiating autophagy.
Gene References Into Functions
  1. TRAPPC8 regulates autophagy and secretory trafficking. It is required for TBC1D14 to bind to TRAPPIII. PMID: 26711178
  2. Research indicates that a disease-causing mutation in TRAPPC2, D47Y, impairs its interaction with TRAPPC9 or TRAPPC8. This suggests that aspartate 47 in TRAPPC2 is located near the binding site for either TRAPPC9 or TRAPPC8. PMID: 21858081
Database Links

HGNC: 29169

OMIM: 614136

KEGG: hsa:22878

STRING: 9606.ENSP00000283351

UniGene: Hs.202001

Protein Families
TRS85 family
Subcellular Location
Golgi apparatus, cis-Golgi network.

Q&A

What is TRAPPC8 and why is it significant in cellular research?

TRAPPC8 (Transport Protein Particle Complex 8) is a critical subunit of the TRAPPIII complex involved in cellular trafficking pathways. It has been identified as a host factor required for human papillomavirus (HPV) infection and may play important roles in intracellular transport. Research has shown that TRAPPC8 is localized both intracellularly and partially on the cell surface, with specific regions (particularly amino acids 880-894) exposed on the plasma membrane . These characteristics make TRAPPC8 an intriguing target for investigating membrane trafficking, viral entry mechanisms, and Golgi function. When studying TRAPPC8, researchers should consider its interactions with other TRAPP complex components such as TRAPPC12, as these relationships may influence experimental outcomes and interpretation .

How does FITC conjugation enhance TRAPPC8 antibody functionality?

FITC (fluorescein isothiocyanate) conjugation chemically links the fluorescent FITC molecule to the antibody structure, typically at a ratio of ≥3 moles fluorescein per mole IgG for optimal detection . This conjugation enables direct visualization of TRAPPC8 in applications such as flow cytometry, immunofluorescence microscopy, and live cell imaging without requiring secondary antibody detection steps. The conjugation process preserves the antibody's specificity while adding fluorescent properties with excitation maximum at approximately 495 nm and emission maximum at approximately 519 nm, resulting in bright green fluorescence. Researchers should verify that the conjugation hasn't altered antibody affinity by comparing results with unconjugated versions in parallel experiments when first establishing protocols .

What are the critical considerations for antibody validation when working with TRAPPC8 antibody, FITC conjugated?

Validation of TRAPPC8 antibodies requires multi-parametric assessment approaches. Begin with Western blot analysis using cell lysates from control and TRAPPC8 knockdown cells to confirm specificity, as demonstrated with various anti-TRAPPC8 antibodies (anti-N1/603, anti-P880/894, or anti-P1270/1285) . Flow cytometry validation should verify both signal intensity and specificity by comparing staining in control versus TRAPPC8-depleted cells. Immunofluorescence microscopy can confirm expected subcellular localization patterns, with particular attention to membrane localization that may vary depending on the epitope targeted by the antibody . For FITC-conjugated antibodies specifically, validation should include assessment of fluorophore-to-protein ratio and lot-to-lot consistency to ensure reliable fluorescence intensity across experiments .

How can TRAPPC8 antibody, FITC conjugated be optimally utilized in flow cytometry experiments?

For flow cytometric detection of TRAPPC8, begin by optimizing antibody concentration through titration experiments, typically starting with manufacturer-recommended dilutions and testing 2-fold serial dilutions above and below this range. Cell preparation is critical - use gentle detachment methods (EDTA rather than trypsin) to preserve cell surface epitopes, as demonstrated in protocols using anti-P880/894 antibodies for TRAPPC8 surface detection . Maintain cells at 4°C during staining to prevent antibody internalization and include appropriate blocking steps (1-2% BSA or serum) to reduce non-specific binding. Critical controls should include: (1) unstained cells, (2) isotype-matched FITC-conjugated control antibody, and (3) cells transfected with TRAPPC8 siRNA to establish background levels . For multicolor panels, include compensation controls and select markers with minimal spectral overlap with FITC to avoid bleed-through issues .

What approaches enable effective colocalization studies using TRAPPC8 antibody, FITC conjugated?

Colocalization studies with TRAPPC8 antibody, FITC conjugated require careful experimental design. Select complementary fluorophores with minimal spectral overlap - red-emitting fluorophores like Alexa Fluor 546 pair well with FITC for dual labeling . When examining TRAPPC8 colocalization with viral particles or cellular structures, sequential staining protocols often yield best results: first stain with TRAPPC8 antibody, FITC conjugated, followed by fixation and staining for the second target. Based on published protocols, confocal microscopy with careful z-stack acquisition is recommended, as TRAPPC8 shows distinct localization patterns at the cell surface that may be missed in single-plane imaging . For quantitative analysis, employ statistical approaches such as Pearson's or Mander's coefficient calculations rather than relying solely on visual assessment of yellow overlap. Importantly, include appropriate controls such as examining TRAPPC8 localization both before and after experimental treatments, as TRAPPC8 distribution can change upon virus inoculation .

How do different epitope-targeting TRAPPC8 antibodies affect experimental outcomes?

Different anti-TRAPPC8 antibodies target distinct epitopes and can yield varying experimental results. Research has demonstrated that antibodies targeting different regions of TRAPPC8 show different localization patterns - specifically, anti-P880/894 (targeting amino acids 880-894) effectively detects TRAPPC8 on the cell surface and shows colocalization with viral particles, while anti-N1/603 (targeting amino acids 1-603) and anti-P1270/1285 (targeting amino acids 1270-1285) show different reactivity patterns . When selecting a FITC-conjugated TRAPPC8 antibody, researchers should carefully consider their experimental goals: for studying intracellular trafficking, antibodies targeting internal domains may be more appropriate, while surface interaction studies benefit from antibodies targeting exposed domains. Validation experiments comparing multiple antibodies targeting different TRAPPC8 regions are recommended when establishing new research models to ensure appropriate epitope accessibility in your experimental system .

What are the optimal storage and handling conditions for maintaining TRAPPC8 antibody, FITC conjugated activity?

FITC-conjugated antibodies require specific storage and handling protocols to maintain optimal activity. Store the antibody between 2°C and 8°C in the dark to prevent photobleaching of the FITC conjugate . Avoid repeated freeze-thaw cycles, as this can lead to protein denaturation and fluorophore degradation. For long-term storage beyond manufacturer recommendations, prepare small single-use aliquots in storage buffer containing a protein stabilizer such as 0.2-1% BSA, similar to formulations used for other FITC-conjugated antibodies . Protect from light during all handling procedures by using amber tubes or wrapping containers in aluminum foil. Before each use, centrifuge the antibody solution briefly to collect liquid that may have accumulated on the cap or sides of the tube. Monitor solution clarity before use - cloudy solutions may indicate antibody aggregation and reduced activity .

How can researchers minimize background and non-specific binding when using TRAPPC8 antibody, FITC conjugated?

Background reduction requires systematic optimization. Begin with effective blocking - use 1-2% BSA or 5-10% serum from the same species as the secondary antibody (if applicable) in PBS for 30-60 minutes prior to antibody application . Cell fixation methods significantly impact background - for TRAPPC8 detection, mild fixation with 2-4% paraformaldehyde preserves epitope structure while minimizing autofluorescence, as demonstrated in protocols using anti-TRAPPC8 antibodies . When performing flow cytometry, include a viability dye to exclude dead cells which often show increased non-specific antibody binding. For microscopy applications, include an additional blocking step with 0.1-0.3M glycine to quench reactive aldehyde groups from fixation. Critical controls should include TRAPPC8 knockdown cells to establish specific versus non-specific staining patterns . If high background persists, titrate antibody concentration further and increase washing duration and volume between staining steps using phosphate-buffered saline with 0.05-0.1% Tween-20 .

What are effective approaches for multiplexing TRAPPC8 antibody, FITC conjugated with other fluorescent markers?

Successful multiplexing requires strategic planning. Begin by carefully selecting fluorophores with minimal spectral overlap with FITC - good choices include far-red dyes (Alexa Fluor 647), red fluorophores (Alexa Fluor 594), or fluorophores in the violet/blue spectrum for multi-color panels . When designing panels, consider instrument configuration and available filters to ensure proper detection of all fluorophores. For flow cytometry applications, perform comprehensive compensation using single-stained controls to correct for spectral overlap. In microscopy applications, capture individual channels sequentially rather than simultaneously to minimize bleed-through, particularly important for colocalization studies of TRAPPC8 with other cellular structures . For applications requiring additional sensitivity, consider alternative strategies such as combining direct detection of TRAPPC8 using FITC-conjugated antibody with amplification methods (e.g., tyramide signal amplification) for less abundant targets in the same sample .

How can TRAPPC8 antibody, FITC conjugated be used to investigate viral entry mechanisms?

TRAPPC8 has been implicated in viral infection pathways, particularly for human papillomavirus (HPV). To investigate its role in viral entry, researchers can employ FITC-conjugated TRAPPC8 antibodies in live-cell imaging experiments to track dynamic interactions between TRAPPC8 and viral particles during cellular entry. Experimental design should include time-course studies capturing images at defined intervals after virus addition . Colocalization analysis with fluorescently labeled viral particles (using antibodies targeting viral capsid proteins such as HPV L1) can reveal temporal relationships between TRAPPC8 redistribution and virus internalization . These experiments can be complemented with functional studies comparing infection efficiency in control versus TRAPPC8-knockdown cells using siRNA approaches, as demonstrated in protocols where TRAPPC8 depletion reduced HPV PsV transduction and authentic HPV infection . For mechanistic insights, combine these approaches with inhibitors of specific endocytic pathways to determine whether TRAPPC8-dependent entry utilizes clathrin-dependent endocytosis, caveolin-mediated pathways, or macropinocytosis .

What methodological approaches enable investigation of TRAPPC8's role in Golgi structure and function using FITC-conjugated antibodies?

TRAPPC8's role in Golgi dynamics can be investigated through complementary approaches. Begin with colocalization studies using FITC-conjugated TRAPPC8 antibodies alongside markers for different Golgi compartments (GM130 for cis-Golgi, TGN46 for trans-Golgi) to establish baseline localization patterns. Research has shown that TRAPPC8 depletion or disruption of its function can induce Golgi dispersal . To investigate this phenomenon, combine immunofluorescence using FITC-conjugated TRAPPC8 antibodies with functional assays such as tracking the trafficking of fluorescently-labeled cargo proteins through the secretory pathway. Time-course experiments comparing Golgi morphology and trafficking efficiency in control versus TRAPPC8-knockdown cells can reveal the temporal relationship between TRAPPC8 depletion and Golgi destabilization . For mechanistic studies, examine the effect of expressing truncated TRAPPC8 variants or specific domains (similar to experiments with GFP-fused L2 that interacted with TRAPPC8) on Golgi structure to identify regions critical for maintaining Golgi integrity .

How can advanced imaging techniques enhance data obtained with TRAPPC8 antibody, FITC conjugated?

Advanced imaging approaches significantly expand research capabilities with FITC-conjugated TRAPPC8 antibodies. Super-resolution microscopy techniques such as Structured Illumination Microscopy (SIM) or Stimulated Emission Depletion (STED) microscopy overcome the diffraction limit of conventional microscopy, enabling visualization of TRAPPC8 distribution with approximately 50-100 nm resolution - particularly valuable for examining TRAPPC8 localization in membrane microdomains . For studying dynamic TRAPPC8 interactions, Förster Resonance Energy Transfer (FRET) approaches can be employed using FITC-conjugated TRAPPC8 antibodies as donors and appropriate acceptor fluorophores conjugated to antibodies against potential interaction partners. Live-cell imaging with spinning disk confocal microscopy enables tracking of TRAPPC8 redistribution during cellular processes such as viral entry with minimal phototoxicity . For quantitative analysis of TRAPPC8 surface expression, Total Internal Reflection Fluorescence (TIRF) microscopy provides excellent signal-to-noise ratio for selective visualization of plasma membrane-associated TRAPPC8 populations, complementing flow cytometry data on surface expression .

How can TRAPPC8 antibody, FITC conjugated be used to validate and monitor TRAPPC8 knockdown efficiency?

Effective knockdown validation requires quantitative approaches. Flow cytometry using FITC-conjugated TRAPPC8 antibodies provides a rapid quantitative assessment of knockdown efficiency at the single-cell level, allowing determination of both the percentage of cells showing reduced TRAPPC8 expression and the degree of reduction in each cell . When establishing knockdown protocols, perform time-course experiments collecting samples at 24, 48, 72, and 96 hours post-transfection to determine optimal timepoints for subsequent experiments, as demonstrated in published TRAPPC8 knockdown studies . Complementary validation should include Western blotting with anti-TRAPPC8 antibodies targeting different epitopes to ensure comprehensive protein reduction rather than simply epitope masking. For microscopy-based validation, compare immunofluorescence intensity of FITC-conjugated TRAPPC8 antibody staining in control versus knockdown cells using standardized exposure settings and quantitative image analysis . Include analysis of both surface and total (permeabilized) TRAPPC8 staining, as these populations may show different depletion kinetics following siRNA treatment.

What is the relationship between TRAPPC8 and other TRAPP complex components, and how can this be studied with fluorescently labeled antibodies?

TRAPPC8 functions as part of the larger TRAPPIII complex, with established interactions with components like TRAPPC12. To investigate these relationships, multiplexed immunofluorescence approaches using FITC-conjugated TRAPPC8 antibodies in combination with antibodies against other TRAPP components enable visualization of their spatial relationships and potential colocalization . Co-immunoprecipitation experiments followed by Western blotting have demonstrated that TRAPPC8 and TRAPPC12 can be co-precipitated with viral L2 proteins, suggesting functional association . To explore functional relationships, researchers can design experiments comparing the effects of individual versus simultaneous knockdown of TRAPPC8 and other TRAPP components on cellular processes such as viral infection, protein trafficking, or Golgi structure. Flow cytometry with appropriate fluorescently-labeled antibodies allows quantitative assessment of whether depletion of one component affects the expression or localization of others . For mechanistic studies, domain mapping through expression of truncated protein variants can identify regions of TRAPPC8 required for interaction with other TRAPP components.

What are the appropriate controls and quantification methods for flow cytometry experiments using TRAPPC8 antibody, FITC conjugated?

Rigorous flow cytometry analysis requires comprehensive controls and standardized quantification. Essential controls include: unstained cells to establish autofluorescence baseline; isotype-matched FITC-conjugated control antibody to assess non-specific binding; positive controls such as cells overexpressing TRAPPC8; and negative controls such as TRAPPC8 knockdown cells . For quantification, mean fluorescence intensity (MFI) provides a more informative measure than percent positive cells when analyzing changes in TRAPPC8 expression levels. When comparing treatment conditions, calculate the ratio of specific staining to isotype control staining (signal-to-noise ratio) rather than using raw MFI values. For time-course experiments, normalize data to the appropriate baseline timepoint. Statistical analysis should include appropriate tests for the experimental design - paired t-tests for before/after comparisons in the same samples or ANOVA for comparing multiple conditions . When analyzing heterogeneous cell populations, consider using viSNE or other dimensionality reduction approaches to identify distinct subpopulations with different TRAPPC8 expression patterns .

How can researchers differentiate between specific and non-specific signals when interpreting results from TRAPPC8 antibody, FITC conjugated staining?

Distinguishing specific from non-specific signals requires systematic approaches. Begin by comparing staining patterns between positive controls (wild-type cells) and negative controls (TRAPPC8 knockdown cells) - specific staining should show significant reduction in knockdown samples . For flow cytometry, establish a positivity threshold based on the fluorescence intensity where less than 1-2% of cells stain positive with isotype-matched FITC-conjugated control antibody. In microscopy applications, compare staining patterns with multiple antibodies targeting different TRAPPC8 epitopes - regions of overlap between different antibodies likely represent specific staining . Competition experiments, where unlabeled TRAPPC8 antibody is pre-incubated before adding FITC-conjugated antibody, can help identify specific binding sites. For surface staining, compare staining patterns between unfixed cells (detecting only surface TRAPPC8) and permeabilized cells (detecting total TRAPPC8) to confirm the specificity of membrane localization . When analyzing colocalization with other markers, quantitative colocalization coefficients provide more objective assessment than visual inspection alone.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.